Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Boyle

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
JCO Precision Oncology|August 12, 2021
<i>TERT</i> Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional RecurrenceYao Yu, Dan Fan, Xinmao Song, et al.
Cancer|February 26, 2020
Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignanciesMing Fan, Jung Julie Kang, Anna Lee, et al.
Thyroid : Official Journal of the American Thyroid Association|February 26, 2024
<i>RAS</i>-Mutated Cytologically Indeterminate Thyroid Nodules: Prevalence of Malignancy and Behavior Under Active SurveillanceHannah J Sfreddo, Elizabeth S Koh, Karena Zhao, et al.
Oral Oncology|April 26, 2023
Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavityYao Yu, Heiko Schöder, Kaveh Zakeri, et al.
CA: a Cancer Journal for Clinicians|October 28, 2022
Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus-associated oropharyngeal cancerJung Julie Kang, Yao Yu, Linda Chen, et al.
Oral Oncology|March 18, 2020
Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancersDan Fan, Jung J Kang, Ming Fan, et al.
JAMA Network Open|November 11, 2022
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation TherapyIrini Youssef, Jennifer Yoon, Nader Mohamed, et al.
JAMA Oncology|November 6, 2015
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical TrialWilliam N William, Vassiliki Papadimitrakopoulou, J Jack Lee, et al.
JAMA Oncology|July 22, 2016
The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing PlatformLuc G T Morris, Raghu Chandramohan, Lyndsay West, et al.
Cancer|July 9, 2020
The 3 Bs of cancer care amid the COVID-19 pandemic crisis: "Be safe, be smart, be kind"-A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancerJung Julie Kang, Richard J Wong, Eric J Sherman, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
JCO Precision Oncology|August 12, 2021
<i>TERT</i> Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional RecurrenceYao Yu, Dan Fan, Xinmao Song, et al.
Cancer|February 26, 2020
Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignanciesMing Fan, Jung Julie Kang, Anna Lee, et al.
Thyroid : Official Journal of the American Thyroid Association|February 26, 2024
<i>RAS</i>-Mutated Cytologically Indeterminate Thyroid Nodules: Prevalence of Malignancy and Behavior Under Active SurveillanceHannah J Sfreddo, Elizabeth S Koh, Karena Zhao, et al.
Oral Oncology|April 26, 2023
Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavityYao Yu, Heiko Schöder, Kaveh Zakeri, et al.
CA: a Cancer Journal for Clinicians|October 28, 2022
Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus-associated oropharyngeal cancerJung Julie Kang, Yao Yu, Linda Chen, et al.
Oral Oncology|March 18, 2020
Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancersDan Fan, Jung J Kang, Ming Fan, et al.
JAMA Network Open|November 11, 2022
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation TherapyIrini Youssef, Jennifer Yoon, Nader Mohamed, et al.
JAMA Oncology|November 6, 2015
Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical TrialWilliam N William, Vassiliki Papadimitrakopoulou, J Jack Lee, et al.
JAMA Oncology|July 22, 2016
The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing PlatformLuc G T Morris, Raghu Chandramohan, Lyndsay West, et al.
Cancer|July 9, 2020
The 3 Bs of cancer care amid the COVID-19 pandemic crisis: "Be safe, be smart, be kind"-A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancerJung Julie Kang, Richard J Wong, Eric J Sherman, et al.
Pageof 11